Also trades as: 4536.T (JPX) · $vol 13M · SNPHF (OTC) · $vol 0M

$10.55

-0.57 (-5.13%)

Weekly Expected Move ±6.1%

$9 $10 $11 $11 $12

OTC · Healthcare · Drug Manufacturers - General · Tech Score Neutral · Power 54 · $3.4B mcap · 315M float · 0.0009% daily turnover · Short 11% of daily vol

Overview Chart Smart Money Financials Income Statement Cash Flow Balance Sheet Earnings

Analysis Technicals Weather Peers ESG Institutions Dark Pool Short Interest

Income Trends

Revenue

$309.2B +3.1% ▲

5Y CAGR: +4.4%

Gross Profit

$170.7B -0.2% ▼

5Y CAGR: +2.4%

Operating Income

$47.9B +2.3% ▲

5Y CAGR: +4.9%

Net Income

$39.6B +9.3% ▲

5Y CAGR: +42.1%

EPS (Diluted)

$121.43 +17.1% ▲

5Y CAGR: +48.1%

EBITDA

$67.4B +14.2% ▲

5Y CAGR: -0.8%

Profit Margins

Year-over-Year Growth

View Full Income Statement

Line Item	FY2022	FY2023	FY2024	FY2025	FY2026
Revenue	$266.3B	$279.0B	$302.0B	$300.0B	$309.2B
YoY Growth	+6.7%	+4.8%	+8.2%	-0.6%	+3.1%
Cost of Revenue	$109.7B	$113.0B	$123.3B	$129.0B	$138.5B
Gross Profit	$156.6B	$166.1B	$178.7B	$171.0B	$170.7B
Gross Margin	58.8%	59.5%	59.2%	57.0%	55.2%
R&D Expenses	$26.4B	$28.3B	$25.4B	$24.1B	$27.8B
SG&A Expenses	$84.5B	$96.3B	$91.5B	$88.0B	$95.0B
Operating Expenses	$120.7B	$169.2B	$140.2B	$124.1B	$122.7B
Operating Income	$35.9B	-$3.1B	$38.5B	$46.9B	$47.9B
Operating Margin	13.5%	-1.1%	12.8%	15.6%	15.5%
Interest Expense	$1.2B	$1.5B	$2.7B	$2.7B	$2.1B
Income Before Tax	$35.6B	-$5.8B	$29.9B	$47.5B	$50.3B
Tax Expense	$8.4B	$9.2B	$3.2B	$11.6B	$10.5B
Net Income	$27.2B	-$14.9B	$26.6B	$36.3B	$39.6B
Net Margin	10.2%	-5.4%	8.8%	12.1%	12.8%
EPS (Diluted)	$67.97	$-38.58	$72.37	$103.68	$121.43
EBITDA	$52.9B	$12.9B	$50.7B	$59.0B	$67.4B
Shares Outstanding	400M	387M	368M	350M	328M

Line Item	FY2025 Q1	FY2025 Q2	FY2025 Q3	FY2025 Q4	FY2026 Q1	FY2026 Q2	FY2026 Q3	FY2026 Q4
Revenue	$74.8B	$71.6B	$76.4B	$77.2B	$68.7B	$70.3B	$74.2B	$82.3B
Cost of Revenue	$32.0B	$31.5B	$34.1B	$31.1B	$31.6B	$31.9B	$35.0B	$31.8B
Gross Profit	$42.8B	$40.1B	$42.2B	$46.1B	$37.1B	$38.5B	$39.2B	$50.6B
Gross Margin	57.2%	56.0%	55.3%	59.7%	54.0%	54.7%	52.9%	61.4%
R&D Expenses	$5.5B	$5.4B	$5.8B	$7.3B	$6.2B	$6.3B	$6.1B	$8.0B
SG&A Expenses	$21.4B	$20.8B	$22.5B	$22.6B	$21.2B	$21.7B	$22.7B	$25.2B
Operating Expenses	$29.6B	$28.1B	$30.5B	$36.2B	$29.5B	$28.0B	$28.8B	$33.2B
Operating Income	$13.2B	$12.1B	$11.8B	$9.9B	$7.6B	$10.5B	$10.5B	$17.4B
Operating Margin	17.6%	16.9%	15.4%	12.8%	11.0%	14.9%	14.1%	21.1%
Interest Expense	$407M	$330M	$0	$9M	$122M	$422M	$324M	$521M
Income Before Tax	$13.4B	$10.4B	$11.5B	$12.2B	$7.5B	$10.4B	$10.6B	$19.7B
Tax Expense	$2.8B	$2.3B	$2.8B	$3.7B	$1.6B	$2.2B	$2.3B	$3.9B
Net Income	$10.6B	$8.1B	$8.7B	$8.8B	$5.9B	$8.2B	$8.0B	$15.8B
Net Margin	14.2%	11.4%	11.4%	11.4%	8.6%	11.7%	10.8%	19.2%
EPS (Diluted)	$29.50	$23.16	$25.22	$25.69	$17.28	$24.00	$24.78	$47.93
EBITDA	$17.9B	$15.1B	$15.8B	$18.5B	$12.1B	$15.6B	$15.7B	$22.0B
Shares Outstanding	360M	351M	345M	341M	340M	340M	324M	326M

SNPHY OTC

Income Trends

Profit Margins

Year-over-Year Growth

Sign in to InsiderStreet